Author Häusler, Darius
-
2018 | Journal Article
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
Häusler, D.; Häusser-Kinzel, S.; Feldmann, L.; Torke, S.; Lepennetier, G.; Bernard, C. C. A. & Zamvil, S. S. et al. (2018)
Proceedings of the National Academy of Sciences, 115(39) pp. 9773-9778. DOI: https://doi.org/10.1073/pnas.1810470115
Details DOI
-
2019 | Journal Article
Reply: Neither human nor mouse is hypercalcaemic with 250 nmol/l 25-hydroxyvitamin D
Häusler, D.; Torke, S.; Peelen, E.; Bertsch, T.; Weber, M.; Heilmann, M. & Djukic, M. et al. (2019)
Brain: A Journal of Neurology, 143(2) pp. e10-e10. DOI: https://doi.org/10.1093/brain/awz389
Details DOI
-
2019 | Journal Article
High dose vitamin D exacerbates central nervous system autoimmunity by raising T-cell excitatory calcium
Häusler, D.; Torke, S.; Peelen, E.; Bertsch, T.; Djukic, M.; Nau, R. & Larochelle, C. et al. (2019)
Brain, 142(9) pp. 2737-2755. DOI: https://doi.org/10.1093/brain/awz190
Details DOI
-
2019 | Journal Article
Reply: Hypercalcaemia rather than high dose vitamin D3 supplements could exacerbate multiple sclerosis
Häusler, D.; Torke, S.; Peelen, E.; Bertsch, T.; Djukic, M.; Nau, R. & Larochelle, C. et al. (2019)
Brain, 142(12) pp. e72-e72. DOI: https://doi.org/10.1093/brain/awz341
Details DOI
-
2019 | Journal Article | Research Paper |
Vitamin D Supplementation in Central Nervous System Demyelinating Disease-Enough Is Enough
Häusler, D. & Weber, M. S. (2019)
International Journal of Molecular Sciences, 20(1) art. 218. DOI: https://doi.org/10.3390/ijms20010218
Details DOI PMID PMC
-
2020 | Journal Article
Glatiramer acetate immune modulates B-cell antigen presentation in treatment of MS
Häusler, D.; Hajiyeva, Z.; Traub, J. W.; Zamvil, S. S.; Lalive, P. H.; Brück, W. & Weber, M. S. (2020)
Neurology - Neuroimmunology Neuroinflammation, 7(3) pp. e698. DOI: https://doi.org/10.1212/NXI.0000000000000698
Details DOI
-
2020 | Journal Article |
High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating Disease
Häusler, D.; Torke, S. & Weber, M. S. (2020)
Frontiers in Immunology, 11. DOI: https://doi.org/10.3389/fimmu.2020.00301
Details DOI
-
2020 | Journal Article |
Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease
Torke, S.; Pretzsch, R.; Häusler, D.; Haselmayer, P.; Grenningloh, R.; Boschert, U. & Brück, W. et al. (2020)
Acta Neuropathologica, 140(4) pp. 535-548. DOI: https://doi.org/10.1007/s00401-020-02204-z
Details DOI
-
2021 | Journal Article | Research Paper |
CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort study
Häusler, D.; Akgün, K.; Stork, L.; Lassmann, H.; Ziemssen, T.; Brück, W. & Metz, I. (2021)
Brain Pathology,. DOI: https://doi.org/10.1111/bpa.12969
Details DOI
-
2021 | Journal Article | Research Paper |
Proinflammatory CD20 + T Cells are Differentially Affected by Multiple Sclerosis Therapeutics
Quendt, C.; Ochs, J.; Häusser‐Kinzel, S.; Häusler, D. & Weber, M. S. (2021)
Annals of Neurology, 90(5) pp. 834-839. DOI: https://doi.org/10.1002/ana.26216
Details DOI